Skip to main content

Table 5 Postoperative laboratory data during the first 3 postoperative days

From: Comparison of dexmedetomidine vs. remifentanil combined with sevoflurane during radiofrequency ablation of hepatocellular carcinoma: a randomized controlled trial

  Remifentanil (n = 47) Dexmedetomidine (n = 47) P
Peak AST (U/L) 293.15 ± 208.68 285.98 ± 131.67 0.843
Peak ALT (U/L) 240.48 ± 196.20 265.17 ± 207.06 0.557
Nadir ALB (g/L) 34.62 ± 5.44 32.92 ± 6.82 0.190
Peak TBIL (μmol/L) 42.32 ± 30.97 49.21 ± 55.05 0.468
Peak PT (s) 17.06 ± 6.26 16.23 ± 5.12 0.522
Nadir PT% activity 71.72 ± 12.68 73.54 ± 13.29 0.540
  1. Values are expressed as mean ± standard deviation
  2. ALT alanine aminotransferase, AST aspartate aminotransferase, ALB albumin, TBIL total bilirubin, PT prothrombin time